Question:
For depot injections, in which drug is slowly released over weeks or months, which bioequivalence study design is used?
For depot injections, in which drug is slowly released over weeks or months, which bioequivalence study design is used?
Updated On: Jul 16, 2024
- Multiple dose study design.
- Replicated crossover study design
- Nonreplicate, parallel study design
- Randomized crossover design
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C): Nonreplicate, parallel study design
Was this answer helpful?
0
0
Top Questions on Bio-availability & Bio-equivalence
- Which type of in-vitro-in-vivo correlation compares % drug released vs % drug absorbed?
- GPAT - 2023
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- Under which of the following conditions in-vitro-in-vivo correlation for a drug fails?
- GPAT - 2023
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- Decrease in effective surface area available to the dissolution medium leading to a fall in the dissolution rate, may happen due to which one of the following reasons?
- GPAT - 2022
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- Match List I with List II
List I List II A When two dosage forms have equal t max I When their total body clearance is constant. B AUC values of the two analogs can be compared to measure relative bioavailability II Absorption rate constants are equal C Urinary data is valid to measure bioavailability. III. W III When fraction absorbed and elimination rate is constant. D C max is proportional to the rate of absorption IV Excretion of drug and/or metabolite is related to the bioavailable dose. Choose the correct answer from the options given below:
- GPAT - 2022
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
- For solid oral drug products, a change in the concentration of which of the following excipients is more likely to influence the bioavailability of a drug.
- GPAT - 2021
- Biopharmaceutics and Pharmacokinetics
- Bio-availability & Bio-equivalence
View More Questions
Questions Asked in GPAT exam
- Core tablet coated with cellulose acetate phthalate has been administered to a patient. Where do you expect the drug to be released:
- GPAT - 2024
- Tablets
- An elixir contains 47 % v/v alcohol, what is the proof spirit according to USP:
- GPAT - 2024
- Liquids(solutions, syrups, elixirs, spirits, aromatic water, liquid for external uses)
- Which of the following is an aryl acetic acid derivative:
- GPAT - 2024
- carbonyl compounds
- Calculate the \( \lambda_{\text{max}} \) of the following molecule:
- GPAT - 2024
- Nucleic acid: replication, transcription, splicing, translation
- The below structure represent the drug:
- GPAT - 2024
- Biogenetic pathways
View More Questions